Can a weekly shot help dialysis patients manage diabetes?

NCT ID NCT06042153

First seen Jan 16, 2026 · Last updated May 15, 2026 · Updated 19 times

Summary

This study tests whether semaglutide, a once-weekly injectable diabetes drug, can improve blood sugar control in people with type 2 diabetes who are on chronic dialysis. About 43 participants will be randomly assigned to receive either semaglutide or a placebo for 13 months. Blood sugar levels will be tracked using a continuous glucose monitor at several points during the study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • DaVita UT Southwestern - East Dallas

    Dallas, Texas, 75228, United States

  • DaVita UT Southwestern - Irving

    Irving, Texas, 75062, United States

  • DaVita UT Southwestern - Preston

    Dallas, Texas, 75240, United States

  • Davita UT Southwestern - Oak Cliff

    Dallas, Texas, 75224, United States

  • University of North Carolina

    Chapel Hill, North Carolina, 27599, United States

Conditions

Explore the condition pages connected to this study.